徐放性添加剤の世界市場レポート 2025年

徐放性添加剤市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.8％で21億3,000万米ドルに成長します。予測期間の成長は、高齢者人口の増加、個別化医療への注目、患者の服薬アドヒアランスの課題、複雑な製剤の増加、疾病管理の進歩、世界のヘルスケアの拡大に起因しています。予測期間における世界の主な動向としては、患者中心のドラッグデリバリー、製剤開発のための共同研究、規制遵守と安全性、製剤技術の世界的拡大、バイオ医薬品の影響などが挙げられます。

慢性疾患と急性疾患の有病率の増加は、徐放性賦形剤市場の成長を促進すると予想されます。慢性疾患は3ヶ月以上持続する長期的な疾患であり、急性疾患は突然発症する症状が特徴で、一般的に重篤であるが数時間から数週間と短期間です。徐放性賦形剤は、慢性疾患と急性疾患の両方の医薬品製剤に一般的に使用され、患者の服薬アドヒアランスを高め、薬物レベルを安定させ、副作用を軽減し、全体的な疾患管理を改善します。これが徐放性賦形剤の需要を牽引しています。例えば、2022年9月、世界保健機関（WHO）は、心血管疾患が非感染性疾患（NCD）の主な死因であり、年間1,790万人が死亡し、次いで慢性呼吸器疾患（410万人）、糖尿病（糖尿病関連腎疾患による死亡を含む200万人）、がん（930万人）が死亡したと報告しました。さらに、米国心臓病学会の2022年8月の報告書では、2025年から2060年にかけて米国における主要な心血管危険因子の増加が予測されており、糖尿病が39.3％増の5,500万例、次いで脂質異常症（27.6％増の1億2,600万例）、高血圧（25.1％増の1億6,200万例）、肥満（18.3％増の1億2,600万例）が続くとされています。また、脳卒中（33.8％→1,500万人）、心不全（33.4％→1,300万人）、虚血性心疾患（30.7％→2,900万人）、心筋梗塞（16.9％→1,600万人）など、心血管疾患の罹患率も増加すると予想されます。このように、慢性および急性疾患の発生率の増加が徐放性賦形剤の需要を牽引しています。

徐放性賦形剤市場はまた、個別化医療に対する需要の高まりからも恩恵を受けると予想されます。個別化医療は、精密医療を使用してカスタマイズされた治療を提供するために、個々の遺伝子、タンパク質、および身体成分を研究することを含みます。徐放性賦形剤は、個々の患者のニーズに合わせた薬剤製剤の開発を促進することで、この分野で重要な役割を果たしています。2022年に米国食品医薬品局（FDA）が承認した個別化医薬品は12品目で、新たに承認された治療用分子実体の約34％を占めると、個別化医療連合（Personalized Medicine Coalition）のThe Scope and Significance of Progress in 2022で報告されています。したがって、個別化医療に対する需要の増加は徐放性賦形剤市場の成長に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界徐放性添加剤PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の徐放性添加剤市場：成長率分析
• 世界の徐放性添加剤市場の実績：規模と成長, 2019-2024
• 世界の徐放性添加剤市場の予測：規模と成長, 2024-2029, 2034F
• 世界徐放性添加剤総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の徐放性添加剤市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ゼラチン
• ポリマー
• 鉱物
• 糖類
• アルコール
• キトサン
• 世界の徐放性添加剤市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 筋肉内
• 皮下
• 経皮
• 膣
• 眼科
• 静脈内
• その他の投与経路
• 世界の徐放性添加剤市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ターゲット配信
• マイクロカプセル化
• ウルスターテクニック
• 経皮
• インプラント
• コアセルベーション
• 世界の徐放性添加剤市場ゼラチンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• A型ゼラチン
• B型ゼラチン
• 世界の徐放性添加剤市場、ポリマーのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 天然ポリマー
• 合成ポリマー
• 世界の徐放性添加剤市場、鉱物の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• カルシウム化合物
• マグネシウム化合物
• その他のミネラル賦形剤
• 世界の徐放性添加剤市場、糖類の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• スクロース
• 乳糖
• グルコース
• その他の糖類
• 世界の徐放性添加剤市場、アルコールの種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• エタノール
• イソプロピルアルコール
• その他のアルコール
• 世界の徐放性添加剤市場キトサンの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 低分子量キトサン
• 高分子量キトサン

第7章 地域別・国別分析

• 世界の徐放性添加剤市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の徐放性添加剤市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 徐放性添加剤市場：競合情勢
• 徐放性添加剤市場：企業プロファイル
  • BASF SE Overview, Products and Services, Strategy and Financial Analysis
  • Ashland Global Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Colorcon Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Croda International Plc Overview, Products and Services, Strategy and Financial Analysis
  • Dow Chemical Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• DuPont de Nemours Inc.
• Roquette Freres
• Evonik Industries AG
• Lubrizol Corporation
• Merck KGaA
• JRS Pharma GmbH & Co. KG
• Shin-Etsu Chemical Co.Ltd.
• Gattefosse SAS
• Eastman Chemical Company
• Cellulose Solutions Private Limited
• Avantor Inc.
• SPI Pharma Inc.
• Asahi Kasei Corporation
• Chemische Fabrik Budenheim KG
• Associated British Foods plc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 徐放性添加剤市場2029：新たな機会を提供する国
• 徐放性添加剤市場2029：新たな機会を提供するセグメント
• 徐放性添加剤市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Sustained-release excipients are pharmaceutical ingredients or additives utilized in formulating drug delivery systems with the aim of achieving controlled or sustained release of active pharmaceutical ingredients (APIs) over an extended period. These excipients play a critical role in regulating the release rate and duration of drug action, optimizing therapeutic efficacy, and enhancing patient compliance.

The primary types of sustained-release excipient products encompass gelatin, polymers, minerals, sugars, alcohol, and chitosan. Gelatin, a protein derived from collagen, the most abundant protein in animal connective tissues such as skin, bones, and tendons, is administered through various routes such as oral, intramuscular, subcutaneous, transdermal, vaginal, ophthalmic, intravenous, and others. Various technologies are employed, including targeted delivery, microencapsulation, the Wurster technique, transdermal delivery, implants, and coacervation.

The sustained release excipients market research report is one of a series of new reports from The Business Research Company that provides sustained release excipients market statistics, including sustained release excipients industry global market size, regional shares, competitors with a sustained release excipients market share, detailed sustained release excipients market segments, market trends and opportunities, and any further data you may need to thrive in the sustained release excipients industry. This sustained release excipients market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sustained release excipients market size has grown strongly in recent years. It will grow from$1.4 billion in 2024 to $1.53 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to increased demand for controlled drug release, chronic disease prevalence, patient compliance and convenience, pharmaceutical industry innovations, regulatory support for extended-release formulations

The sustained release excipients market size is expected to see strong growth in the next few years. It will grow to $2.13 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing geriatric population, focus on personalized medicine, challenges in patient adherence, rise in complex drug formulations, advancements in disease management, global healthcare expansion. Major trends in the forecast period include patient-centric drug delivery, collaborations for formulation development, regulatory compliance and safety, global expansion of drug formulation technologies, influence of biopharmaceuticals.

The rising prevalence of chronic and acute diseases is expected to fuel the growth of the sustained-release excipients market. Chronic diseases are long-term conditions that persist for three months or more, while acute diseases are marked by a sudden onset of symptoms that are typically severe but short-lived, lasting from hours to weeks. Sustained-release excipients are commonly used in pharmaceutical formulations for both chronic and acute diseases, enhancing patient adherence, maintaining stable drug levels, reducing side effects, and improving overall disease management. This drives demand for sustained-release excipients. For instance, in September 2022, the World Health Organization (WHO) reported that cardiovascular diseases were the leading cause of non-communicable disease (NCD) deaths, resulting in 17.9 million deaths annually, followed by chronic respiratory illnesses (4.1 million), diabetes (2 million, including deaths from diabetes-related kidney disease), and cancer (9.3 million). Additionally, an August 2022 report from the American College of Cardiology projected a rise in major cardiovascular risk factors in the U.S. from 2025 to 2060, with diabetes expected to increase by 39.3% to 55 million cases, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). Cardiovascular disease rates are also anticipated to increase for stroke (33.8% to 15 million), heart failure (33.4% to 13 million), ischemic heart disease (30.7% to 29 million), and heart attacks (16.9% to 16 million). Thus, the growing incidence of chronic and acute diseases is driving the demand for sustained-release excipients.

The sustained-release excipients market is also expected to benefit from the growing demand for personalized medicine. Personalized medicine involves studying individual genes, proteins, and bodily components to provide customized care using precision medicine. Sustained-release excipients play a crucial role in this field by facilitating the development of drug formulations tailored to individual patient needs. In 2022, the US Food and Drug Administration (FDA) approved 12 personalized medicines, accounting for approximately 34% of all newly approved therapeutic molecular entities, as reported by The Scope and Significance of Progress in 2022 by the Personalized Medicine Coalition. Therefore, the increasing demand for personalized medicine contributes to the growth of the sustained-release excipients market.

The sustained-release excipients market is witnessing a significant trend of product innovation. Major companies in this market are actively engaged in developing innovative products to enhance their market position. For instance, in September 2022, Nutriventia Limited, an India-based pharmaceutical company, introduced Prolanza, a sustained-release ashwagandha ingredient (Withania somnifera). Prolanza, an advanced Ashwagandha root-only extract, provides continuous stress-reduction support with a unique release mechanism, allowing therapeutic effects over an extended period with a once-daily dose. This sustained-release profile was demonstrated through better relative absorption, improved bioavailability, and a longer elimination half-life compared to the control component. Manufactured from natural herbs, Prolanza has been clinically proven to be effective.

Major companies in the sustained-release excipients market are directing their efforts toward technological innovations, including direct compression solutions, to gain a competitive advantage. Direct compression is an efficient tablet manufacturing process involving the direct conversion of a blend of active pharmaceutical ingredients (APIs) and excipients into tablets without additional steps such as granulation or wet massing. For example, in October 2022, Roquette Freres, a France-based provider of plant-based ingredients, introduced PEARLITOL CR-H and PEARLITOL 200 GT for direct compression. PEARLITOL CR-H, a patented blend of mannitol and hydroxypropyl methylcellulose (HPMC), allows sustained release of APIs in direct compression formulations. PEARLITOL 200 GT, a granulated form of mannitol, enhances the flowability and tabletability of direct compression formulations.

In March 2024, France-based pharmaceutical excipient provider Roquette acquired IFF Pharma Solutions for an undisclosed sum. This acquisition is intended to bolster Roquette's presence in the pharmaceutical excipients market. IFF Pharma Solutions, a U.S.-based company, specializes in manufacturing sustained-release excipients, which are key ingredients in pharmaceutical formulations designed to regulate the release rate of active pharmaceutical ingredients (APIs).

Major companies operating in the sustained release excipients market include BASF SE, Ashland Global Holdings Inc., Colorcon Inc., Croda International Plc, Dow Chemical Company, DuPont de Nemours Inc., Roquette Freres, Evonik Industries AG, Lubrizol Corporation, Merck KGaA, JRS Pharma GmbH & Co. KG, Shin-Etsu Chemical Co.Ltd., Gattefosse SAS, Eastman Chemical Company, Cellulose Solutions Private Limited, Avantor Inc., SPI Pharma Inc., Asahi Kasei Corporation, Chemische Fabrik Budenheim KG, Associated British Foods plc, Ransom Naturals Ltd, Balchem Corporation, IMCD Group, Lonza Group AG

North America was the largest region in the global sustained release excipients market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sustained release excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the sustained release excipients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The sustained-release excipients market consists of sales of ethyl cellulose, lipid-based excipients, waxes, fatty acids, polyethylene glycol (PEG), copovidone, and osmotic agents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sustained Release Excipients Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sustained release excipients market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sustained release excipients ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sustained release excipients market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Gelatin; Polymers; Minerals; Sugars; Alcohol; Chitosan
• 2) By Route of Administration: Oral; Intramuscular; Subcutaneous; Transdermal; Vaginal; Ophthalmic; Intravenous; Other Routes of Administration
• 3) By Technology: Targeted Delivery; Micro Encapsulation; Wurster Technique; Transdermal; Implants; Coacervation
• Subsegments:
• 1) By Gelatin: Type A Gelatin; Type B Gelatin
• 2) By Polymers: Natural Polymers; Synthetic Polymers
• 3) By Minerals: Calcium Compounds; Magnesium Compounds; Other Mineral Excipients
• 4) By Sugars: Sucrose; Lactose; Glucose; Other Sugars
• 5) By Alcohol: Ethanol; Isopropyl Alcohol; Other Alcohols
• 6) By Chitosan: Low Molecular Weight Chitosan; High Molecular Weight Chitosan
• Companies Mentioned: BASF SE; Ashland Global Holdings Inc.; Colorcon Inc.; Croda International Plc; Dow Chemical Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sustained Release Excipients Market Characteristics

3. Sustained Release Excipients Market Trends And Strategies

4. Sustained Release Excipients Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Sustained Release Excipients Growth Analysis And Strategic Analysis Framework

• 5.1. Global Sustained Release Excipients PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Sustained Release Excipients Market Growth Rate Analysis
• 5.4. Global Sustained Release Excipients Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Sustained Release Excipients Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Sustained Release Excipients Total Addressable Market (TAM)

6. Sustained Release Excipients Market Segmentation

• 6.1. Global Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gelatin
• Polymers
• Minerals
• Sugars
• Alcohol
• Chitosan
• 6.2. Global Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intramuscular
• Subcutaneous
• Transdermal
• Vaginal
• Ophthalmic
• Intravenous
• Other Routes of Administration
• 6.3. Global Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Targeted Delivery
• Micro Encapsulation
• Wurster Technique
• Transdermal
• Implants
• Coacervation
• 6.4. Global Sustained Release Excipients Market, Sub-Segmentation Of Gelatin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Type A Gelatin
• Type B Gelatin
• 6.5. Global Sustained Release Excipients Market, Sub-Segmentation Of Polymers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural Polymers
• Synthetic Polymers
• 6.6. Global Sustained Release Excipients Market, Sub-Segmentation Of Minerals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Calcium Compounds
• Magnesium Compounds
• Other Mineral Excipients
• 6.7. Global Sustained Release Excipients Market, Sub-Segmentation Of Sugars, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sucrose
• Lactose
• Glucose
• Other Sugars
• 6.8. Global Sustained Release Excipients Market, Sub-Segmentation Of Alcohol, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ethanol
• Isopropyl Alcohol
• Other Alcohols
• 6.9. Global Sustained Release Excipients Market, Sub-Segmentation Of Chitosan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Low Molecular Weight Chitosan
• High Molecular Weight Chitosan

7. Sustained Release Excipients Market Regional And Country Analysis

• 7.1. Global Sustained Release Excipients Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Sustained Release Excipients Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sustained Release Excipients Market

• 8.1. Asia-Pacific Sustained Release Excipients Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sustained Release Excipients Market

• 9.1. China Sustained Release Excipients Market Overview
• 9.2. China Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sustained Release Excipients Market

• 10.1. India Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sustained Release Excipients Market

• 11.1. Japan Sustained Release Excipients Market Overview
• 11.2. Japan Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sustained Release Excipients Market

• 12.1. Australia Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sustained Release Excipients Market

• 13.1. Indonesia Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sustained Release Excipients Market

• 14.1. South Korea Sustained Release Excipients Market Overview
• 14.2. South Korea Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sustained Release Excipients Market

• 15.1. Western Europe Sustained Release Excipients Market Overview
• 15.2. Western Europe Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sustained Release Excipients Market

• 16.1. UK Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sustained Release Excipients Market

• 17.1. Germany Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sustained Release Excipients Market

• 18.1. France Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sustained Release Excipients Market

• 19.1. Italy Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sustained Release Excipients Market

• 20.1. Spain Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sustained Release Excipients Market

• 21.1. Eastern Europe Sustained Release Excipients Market Overview
• 21.2. Eastern Europe Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sustained Release Excipients Market

• 22.1. Russia Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sustained Release Excipients Market

• 23.1. North America Sustained Release Excipients Market Overview
• 23.2. North America Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sustained Release Excipients Market

• 24.1. USA Sustained Release Excipients Market Overview
• 24.2. USA Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sustained Release Excipients Market

• 25.1. Canada Sustained Release Excipients Market Overview
• 25.2. Canada Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sustained Release Excipients Market

• 26.1. South America Sustained Release Excipients Market Overview
• 26.2. South America Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sustained Release Excipients Market

• 27.1. Brazil Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sustained Release Excipients Market

• 28.1. Middle East Sustained Release Excipients Market Overview
• 28.2. Middle East Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sustained Release Excipients Market

• 29.1. Africa Sustained Release Excipients Market Overview
• 29.2. Africa Sustained Release Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Sustained Release Excipients Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Sustained Release Excipients Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sustained Release Excipients Market Competitive Landscape And Company Profiles

• 30.1. Sustained Release Excipients Market Competitive Landscape
• 30.2. Sustained Release Excipients Market Company Profiles
  • 30.2.1. BASF SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Ashland Global Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Colorcon Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Croda International Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Dow Chemical Company Overview, Products and Services, Strategy and Financial Analysis

31. Sustained Release Excipients Market Other Major And Innovative Companies

• 31.1. DuPont de Nemours Inc.
• 31.2. Roquette Freres
• 31.3. Evonik Industries AG
• 31.4. Lubrizol Corporation
• 31.5. Merck KGaA
• 31.6. JRS Pharma GmbH & Co. KG
• 31.7. Shin-Etsu Chemical Co.Ltd.
• 31.8. Gattefosse SAS
• 31.9. Eastman Chemical Company
• 31.10. Cellulose Solutions Private Limited
• 31.11. Avantor Inc.
• 31.12. SPI Pharma Inc.
• 31.13. Asahi Kasei Corporation
• 31.14. Chemische Fabrik Budenheim KG
• 31.15. Associated British Foods plc

32. Global Sustained Release Excipients Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sustained Release Excipients Market

34. Recent Developments In The Sustained Release Excipients Market

35. Sustained Release Excipients Market High Potential Countries, Segments and Strategies

• 35.1 Sustained Release Excipients Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Sustained Release Excipients Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Sustained Release Excipients Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer